
Opinion|Videos|August 27, 2024
Advances in MDS Classification and Molecular Understanding
After a brief introduction, medical experts discuss advances in MDS classification and molecular understanding.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- How has the new WHO (5th edition and ICC classification scheme for MDS impacted our understanding and management, particularly in distinguishing lower and higher risk categories?
- How has our understanding of the molecular landscape of MDS evolved, and how does this knowledge inform personalized treatment approaches?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
FDA Approves Lumateperone as Add-On Therapy for Major Depressive Disorder
3
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
4
Preventing Tomorrow’s High-Cost Claims: The Rising-Risk Patient Opportunity in Medicaid
5











































